Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san francisco blog main
9
×
startups
9
×
san francisco top stories
deals
national top stories
new york blog main
boston blog main
cancer
fda
san diego blog main
san diego top stories
takeda pharmaceutical
boston top stories
boulder/denver blog main
clinical trials
drugs
new york top stories
shire
alphabet
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
generic drugs
gv
indiana blog main
indiana top stories
investing
ipo
medical device
national
novartis
raleigh-durham blog main
raleigh-durham top stories
roboticsai
san francisco
seattle blog main
What
drugs
9
×
new
bio
roundup
advance
available
biological
biologics
biology
can’t
cells
clears
company
convenience
cytokine
developing
digestive
enhanced
enzymes
humans
hurdle
pharmaceutical
pill
proteins
rani’s
robotic
san
suite
survive
swallowing
synthetic
synthorx
that’s
therapies
adds
ahead
aims
analyzes
appetite
approach
Language
unset
Current search:
drugs
×
startups
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs